tm logo

Monitor this mark

View On USPTO

KEVZARA
Live/Registered
SECTION 8-ACCEPTED

accepted

on 30 Nov 2021

Last Applicant/ Owned by

SANOFI BIOTECHNOLOGY

54, RUE LA BOÉTIE

PARIS

FR

75008

Serial Number

86394577 filed on 15th Sep 2014

Registration Number

4780600 registered on 28th Jul 2015

in the Principal Register

Correspondent Address

Karen Lim

Karen Lim FROSS ZELNICK LEHRMAN & ZISSU, P.C.

NEW YORK, NY 10036

UNITED STATES

Filing Basis

No Filing Basis

Disclaimer

NO DATA

KEVZARA

Pharmaceutical products for the treatment of autoimmune diseases, inflammatory diseases, rheumatoid arthritis and ankylosing spondylarthritis

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical products for the treatment of autoimmune diseases, inflammatory diseases, rheumatoid arthritis and ankylosing spondylarthritis

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 86394577

Mark Type

No Service/Collective Mark

Attorney Docket Number

No SYN 1406973

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
28th Jul 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
30th Nov 2021NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
30th Nov 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30th Nov 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED
12th Jul 2021TEAS SECTION 8 RECEIVED
28th Jul 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08th Jan 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
10th Dec 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
05th Apr 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
31st Jan 2017CORRESPONDENCE RECEIVED IN LAW OFFICE